Neuroscience Drug Development Europe 2026 (Light)

Where Big Attendance Meets Intimate Connections

Highlights of the Two-Day Event

15 - 16 June 2026
Estrel Congress Centre, Berlin, Germany


Step into the future of discovering & developing the next blockbuster drugs at Neuroscience Drug Development Europe 2026 - where groundbreaking science meets collaborative innovation. Featuring the below highlights, our aim is to accelerate breakthroughs and empower all our attendees to connect, collaborate, and drive meaningful progress in the field. 


Cross-Programme Highlights


DAY ONE & TWO

AI & Digitalisation Zone

The AI & Digitalisation Zone will be hosted in the exhibition area and will serve as the central hub for AI-driven drug discovery, digital R&D, and next-generation platform technologies, bringing together innovators such as Recursion, Iktos, Structural Genomics Consortium, and other leaders across AI discovery platforms, cloud infrastructure, automation, bioinformatics, digital biology, academic hubs, and strategic pharma tech partners. This interactive space will feature poster presentations, live demos, and short tech talks, alongside an AI Networking Lounge and a coffee cart to foster meaningful connections and collaboration


DAY ONE

Networking at the Heart of Discovery & Development Europe

Experience Berlin like never before with our VR Formula One racing tour, followed by an evening of drinks, wine tasting, and invite-only exclusive dinner. Connect with peers, unwind, and enjoy the city’s sights in a relaxed, social setting.


Keynote Addresses



DAY ONE

Opening Keynote Address

Rafal Kaminski,
Chief Scientific Officer, Angelini Pharma 

Rafal is a neuroscience-focused innovator driving the next generation of therapies for brain and nervous system disorders. He leads the company’s scientific vision, translating cutting-edge neuroscience research into transformative medicines that address unmet patient needs, blending deep biology insight with precision drug development.



Other Highlights


DAY ONE

Panel Discussion: Is Neuroscience The Next Oncology? Industry Trends In Therapeutic Focus

This panel explores whether neuroscience is reaching an oncology-like era of investment and innovation. Leaders will discuss shifting R&D priorities, progress in biomarkers and human-relevant models, and what is needed to translate neurological research into sustained therapeutic success. 

DAY TWO

Closed-Door Panel Discussion: Partnerships, Platforms Or Acquisitions: What Is The Winning Model For Brain Health Innovation?

This closed-door panel explores what it truly takes to succeed in brain health innovation, covering pharma-biotech-academia collaboration models that actually work, when to partner vs acquire vs build internally, and how to approach data-sharing in a competitive landscape. The discussion will also examine public-private partnerships in Europe — the success stories and the failures — alongside regional differences between the US and EU, and the unique challenges of scaling in Europe.


Connect and Network

Experience an event that celebrates meaningful, one-on-one connections in a dynamic, bustling atmosphere. With Neuroscience Drug Development Europe 2026, enjoy a vibrant crowd with the warmth of personal interactions and curated experiences